NeoVista’s Sights Remain On Underserved AMD Market
The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.
The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.
The company’s SpaceOAR System is designed to temporarily separate organs during radiotherapy so that normal tissues are spared, and to mark tumor resection sites to allow for targeted therapy.
Copyright © 2024 | WordPress Theme by MH Themes